Community-acquired pneumonia mortality: a potential link to recent antibiotic prescribing trends in England and Wales

D. B. Price, D. Honeybourne, P. Little, R. T. Mayon-White, R. C. Read, M. Thomas, M. C. Wale, P. FitzGerald, A. R. Weston (Aberdeen, Birmingham, Oxford, Gloucester, Nottingham, United Kingdom; Chatswood, Newcastle, Australia)

Source: Annual Congress 2002 - Asthma, COPD and management in primary care
Session: Asthma, COPD and management in primary care
Session type: Poster Discussion
Number: 2455
Disease area: Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
D. B. Price, D. Honeybourne, P. Little, R. T. Mayon-White, R. C. Read, M. Thomas, M. C. Wale, P. FitzGerald, A. R. Weston (Aberdeen, Birmingham, Oxford, Gloucester, Nottingham, United Kingdom; Chatswood, Newcastle, Australia). Community-acquired pneumonia mortality: a potential link to recent antibiotic prescribing trends in England and Wales. Eur Respir J 2002; 20: Suppl. 38, 2455

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Incidence of community-acquired pneumonia episodes in COPD patients in England and Wales
Source: Eur Respir J 2007; 30: Suppl. 51, 628s
Year: 2007

Risk factors and implications for readmission of patients following hospitalization for community-acquired pneumonia in South Korea
Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia
Year: 2019


New evidence of risk factors for community-acquired pneumonia: a population-based study
Source: Eur Respir J 2008; 31: 1274-1284
Year: 2008



Cost and outcomes of pneumococcal community-acquired pneumonia among adults in the United Kingdom
Source: Annual Congress 2011 - Assessment of severity and predictors of outcomes in community-acquired pneumonia
Year: 2011


Mortality during hospitalisation for pneumonia in Alberta, Canada, is associated with physician volume
Source: Eur Respir J 2003; 22: 148-155
Year: 2003



Community-acquired pneumonia in pediatric patients: New diagnostic priorities
Source: Annual Congress 2012 - Asthma management
Year: 2012

Community-acquired pneumonia in five European countries: Usage patterns and real-life effectiveness of antibiotics (REACH study)
Source: Annual Congress 2012 - Anti-infective treatment and resistance in respiratory infections
Year: 2012


Hospital admissions of adults with community-acquired pneumonia in Portugal between 2000 and 2009
Source: Eur Respir J 2013; 41: 1141-1146
Year: 2013



Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome
Source: Eur Respir J 2008; 32: 892-901
Year: 2008



The effects of antibiotic therapy at the pre-hospital stage on the in-hospital mortality in adults with community-acquired pneumonia in Russia: observational study results.
Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice
Year: 2020


Epidemiological impact of antibiotic use/misuse in the community
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=165
Year: 2004

Severe community-acquired pneumonia in China: epidemiology and clinical practice
Source: International Congress 2019 – Chinese programme 2019: Part II
Year: 2019


Impact of methicillin resistance on mortality in Staphylococcus aureus VAP: a systematic review
Source: Eur Respir J 2008; 31: 625-632
Year: 2008



Factors associated with hospital mortality in community-acquired legionellosis in France
Source: Eur Respir J 2012; 39: 963-970
Year: 2012



Factors associated with community-acquired pneumonia in-hospital mortality in Portugal
Source: Virtual Congress 2021 – Epidemiology and burden of tuberculosis and other lung diseases
Year: 2021


Determinants of performance of indicators on antibiotic use in community-acquired pneumonia (CAP) at hospitals
Source: Eur Respir J 2005; 26: Suppl. 49, 638s
Year: 2005

Trends in empiric antimicrobial therapy and efficiency of care for community-acquired pneumonia in hospitalized Belarussian patients
Source: Annual Congress 2007 - Antibiotic treatment in community-acquired pneumonia
Year: 2007


Community-acquired pneumonia as an emergency: time for an aggressive intervention to lower mortality
Source: Eur Respir J 2011; 38: 253-260
Year: 2011



Evolution of antimicrobial resistance trends in the last five years in patients with bacteremic Pneumococcal community-acquired pneumonia (CAP-SP)
Source: Eur Respir J 2005; 26: Suppl. 49, 639s
Year: 2005

The impact of 2016 guideline on clinical practice for the management of hospital-acquired and ventilator-associated pneumonia in Taiwan
Source: International Congress 2018 – Difficult-to-treat respiratory infections
Year: 2018